Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 77 Stomach Neoplasms 14 Neoplasms 8 Neoplasm Metastasis 8 HER2-positive Breast Cancer 4 Esophageal Neoplasms 4 Colorectal Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Brain Neoplasms 4 Inflammatory Breast Neoplasms 3 Breast Neoplasms, Male 3 Triple Negative Breast Neoplasms 2 Recurrence 2 Ovarian Neoplasms 2 Cardiotoxicity 2 Urologic Neoplasms 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Solid Tumor 1 Salivary Gland Neoplasms 1 Rectal Neoplasms 1 Pancreatic Neoplasms 1 Neoplastic Cells, Circulating 1 Myeloproliferative Disorders 1 Mycosis Fungoides 1 Multiple Myeloma 1 Meningeal Neoplasms 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, B-Cell, Marginal Zone 1

Interventions

Letrozole 2 Goserelin 2 Fulvestrant 2 olaparib 1 abemaciclib 1 Trastuzumab 1 Lead 1 Aromatase Inhibitors 1 Anastrozole 1 Alpelisib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Advanced Breast Cancer × Trastuzumab × Clear all

NCT03931551 2023-02-22

OPHELIA

MedSIR

Phase 2 Terminated

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡